A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of a Single Dose of Donzakimig in Healthy Chinese and Japanese Participants
Clinical trial NCT06716879 · COMPLETED
Trial details
- NCT number
- NCT06716879
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-06
- Primary completion
- 2025-04-04
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.